Business Wire

Horizon3.ai Raises $100M to Cement Leadership in Autonomous Security

Share

Horizon3.ai, the company behind the NodeZero® Autonomous Security Platform, today announced a $100 million Series D funding round led by NEA, with participation from SignalFire, Craft Ventures and 9Yards Capital. As part of the investment, Lila Tretikov, Partner and Head of AI Strategy at NEA and former Deputy CTO of Microsoft, will join the Horizon3.ai Board of Directors.

“Over the past four years, we’ve proven that using AI to hack companies isn’t science fiction—it’s real, and it’s delivering measurable results at scale. There are now over 3,000 organizations using NodeZero globally to conduct penetration tests. We’re sustaining 100%+ year-over-year ARR growth, and we are now Rule of 40-positive, which means we’re not just growing—we’re growing efficiently,” said Snehal Antani, CEO and Co-founder of Horizon3.ai. “This raise marks the next chapter in our mission to lead the Autonomous Security category.”

“Security teams are tired of chasing CVEs, false positives, and compliance checkboxes. They want to find and fix what actually matters, verify it’s resolved, and go home early,” said Antani. “The hardest part of the job as a CIO is deciding what not to fix. The second hardest part is proving to the board that your security initiatives are meaningfully reducing risk. NodeZero plays a critical role in reducing your threat exposure over time.”

Targeting an $80B Total Addressable Market: Autonomous Security

The cybersecurity market is undergoing a generational shift. NodeZero successfully compromised a bank in 4 minutes with no humans required, far faster than the reaction time of the bank’s security team and their best-in-class tools. Similarly, adversaries are leveraging AI to exponentially increase the sophistication, complexity, speed and scale of attacks. The Horizon3.ai thesis is simple: the future of cyber will be algorithms fighting algorithms—at machine speed—with humans by exception. This requires a fundamental rebuild of every part of the cybersecurity stack. And to do so effectively, you need a deep understanding of how attackers operate—and an AI system that can use offensive insights to drive defensive improvements. Horizon3.ai is leading this shift.

Horizon3.ai has already realized what others are just beginning to imagine. NodeZero is a fully autonomous security system operating in live production environments—executing real attacks, uncovering real risk, and delivering real results,” said Antani.

Powered by reinforcement learning, graph reasoning, and AI, NodeZero doesn't simulate adversaries—it thinks and acts like one. Each cyber attack against production systems executed by NodeZero collects training data used to improve its algorithms, creating a compounding data advantage that no other platform can match. This is the foundation for the next era of cybersecurity, where AI doesn’t just find risk, but continuously improves defenses. Horizon3.ai isn’t chasing the future—it’s building it.

Use of Proceeds: Accelerating Toward the Future

With this funding, Horizon3 is accelerating across three strategic fronts:

  • Scale through partners – Doubling down on its partner ecosystem to meet growing demand across the Americas, EMEA, and APAC.
  • Product innovation – Expanding into web application pentesting, vulnerability management, and precision defense, where NodeZero can remediate findings and tune defensive tools.
  • Winning the federal market – Scaling its success with the Defense Industrial Base through the NSA’s Continuous Autonomous Pentesting (CAPT) program, accelerating FedRAMP High usage, and expanding into Secret and Top Secret workloads to help secure the nation’s most mission-critical systems.

“What drew us to Horizon3.ai is the clarity of their mission and the speed at which they’re executing it,” saidAaron Jacobson, Partner at NEA. “They are defining a new security category—autonomous security—and are already the go-to solution for red and blue teams alike. We’re thrilled to lead this round and support the company’s next phase of growth.”

“Snehal and the Horizon3.ai team are tackling one of the biggest problems in cybersecurity: automating both sides to ensure maximum defensibility against automated and AI-driven attacks,” said Lila Tretikov, Partner and Head of AI Strategy at NEA. “Their customers love NodeZero, and the team has proven to operate with excellence at scale, which is why Horizon3.ai is transforming how security is done. I’m excited to join the board and help shape this next chapter.”

The impact is immediate and measurable. In one recent pentest, NodeZero gained access to sensitive US aircraft carrier design data through a third-party supplier. No humans were involved in the pentest. The platform autonomously compromised the network, gained access to sensitive data, and then guided defenders on exactly what to fix to prevent a breach.

“My old boss used to say, ‘don’t tell me we’re secure, show me, then show me again tomorrow, and again next week, because our environment is always changing and the enemy always has a vote,’” said Antani.

To learn more about NodeZero visit www.horizon3.ai.

For media inquiries and interviews, please see the Media Contact below.

About Horizon3.ai

Horizon3.ai is the leader in autonomous security. Our platform, NodeZero, continuously finds and exploits real-world attack paths so defenders can fix what matters and prove they’re secure. Founded by former U.S. Special Operations cyber operators and enterprise security leaders, Horizon3.ai is trusted by over 3,000 organizations worldwide—from Fortune 500 companies to national defense partners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250610254822/en/

Contacts

Media Contact:
Ed Kraft
SourceCode Communications
horizon3@sourcecodecomms.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release

Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i

Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release

Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d

The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release

Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release

4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release

Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye